全球膽囊治療市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計膽囊治療市場將從 2025 年的 40.9 億美元成長到 2034 年的 65.1 億美元，2026 年至 2034 年的複合年成長率為 5.31%。

由於膽結石和發炎等膽囊相關疾病的發生率不斷上升，全球膽囊治療市場正在成長。治療方案包括藥物治療、微創手術、腹腔鏡膽囊切除術等外科手術。人們對消化系統健康的日益重視以及醫療保健服務可近性的提高，都促進了對有效膽囊治療的需求。

市場擴張的促進因素包括生活方式的改變、飲食習慣的改變以及與膽囊疾病相關的肥胖症的增加。診斷技術和微創手術技術的進步改善了治療效果並縮短了復原時間。醫療機構正在加快採用先進的治療方法，以提升患者照護。

預計未來膽囊治療市場將持續成長，這主要得益於醫療技術的不斷進步和全球醫療基礎設施的改善。藥物療法和外科手術創新研究的持續深入將有助於開發更有效的治療方法。此外，人們對膽囊疾病的認知不斷提高以及醫療服務可近性的改善預計也將增加對膽囊治療方案的需求。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球膽囊治療市場：依治療類型分類

• 市場分析、洞察與預測
• 外科手術
• 藥物
• 非侵入性手術

第5章：全球膽囊治療市場：依適應症分類

• 市場分析、洞察與預測
• 膽囊炎
• 膽結石
• 膽道動力障礙

第6章 全球膽囊治療市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院
• 專科診所
• 門診手術中心

第7章 全球膽囊治療市場：依給藥途徑分類

• 市場分析、洞察與預測
• 口服
• 注射藥物
• 局部的

第8章 全球膽囊治療市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Abbott Laboratories
  • Smith And Nephew
  • Hologic
  • AngioDynamics
  • Thermo Fisher Scientific
  • Cook Medical
  • Baxter International
  • Johnson & Johnson
  • Stryker
  • Fujifilm Holdings
  • Karl Storz
  • CR Bard
  • Medtronic
  • Olympus Corporation
  • Boston Scientific

The Gallbladder Treatment Market size is expected to reach USD 6.51 Billion in 2034 from USD 4.09 Billion (2025) growing at a CAGR of 5.31% during 2026-2034.

The Global Gallbladder Treatment Market is experiencing growth due to the increasing prevalence of gallbladder-related disorders such as gallstones and inflammation. Treatment options include medications, minimally invasive procedures, and surgical interventions such as laparoscopic cholecystectomy. The growing awareness of digestive health and improved access to healthcare services are contributing to the demand for effective gallbladder treatments.

Market expansion is driven by lifestyle changes, dietary habits, and the rising incidence of obesity, which are associated with gallbladder disorders. Advances in diagnostic technologies and minimally invasive surgical techniques are improving treatment outcomes and reducing recovery times. Healthcare providers are increasingly adopting advanced treatment approaches to improve patient care.

Looking forward, the gallbladder treatment market is expected to grow as medical technology continues to advance and healthcare infrastructure improves worldwide. Increasing research in pharmaceutical therapies and surgical innovations will support the development of more effective treatment options. With rising awareness and improved healthcare access, the demand for gallbladder treatment solutions is projected to increase.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Treatment Type

• Surgery
• Medication
• Non-invasive Procedures

By Indication

• Cholecystitis
• Gallstones
• Biliary Dyskinesia

By End User

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers

By Route of Administration

• Oral
• Injectable
• Topical

COMPANIES PROFILED

• Abbott Laboratories, Smith and Nephew, Hologic, AngioDynamics, Thermo Fisher Scientific, Cook Medical, Baxter International, Johnson Johnson, Stryker, Fujifilm Holdings, Karl Storz, CR Bard, Medtronic, Olympus Corporation, Boston Scientific
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL GALLBLADDER TREATMENT MARKET: BY TREATMENT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Treatment Type
• 4.2. Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Medication Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Non-invasive Procedures Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL GALLBLADDER TREATMENT MARKET: BY INDICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Indication
• 5.2. Cholecystitis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Gallstones Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Biliary Dyskinesia Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL GALLBLADDER TREATMENT MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Specialty Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL GALLBLADDER TREATMENT MARKET: BY ROUTE OF ADMINISTRATION 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Route Of Administration
• 7.2. Oral Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Injectable Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Topical Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL GALLBLADDER TREATMENT MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Treatment Type
  • 8.2.2 By Indication
  • 8.2.3 By End User
  • 8.2.4 By Route Of Administration
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Treatment Type
  • 8.3.2 By Indication
  • 8.3.3 By End User
  • 8.3.4 By Route Of Administration
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Treatment Type
  • 8.4.2 By Indication
  • 8.4.3 By End User
  • 8.4.4 By Route Of Administration
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Treatment Type
  • 8.5.2 By Indication
  • 8.5.3 By End User
  • 8.5.4 By Route Of Administration
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Treatment Type
  • 8.6.2 By Indication
  • 8.6.3 By End User
  • 8.6.4 By Route Of Administration
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL GALLBLADDER TREATMENT INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Abbott Laboratories
  • 10.2.2 Smith And Nephew
  • 10.2.3 Hologic
  • 10.2.4 AngioDynamics
  • 10.2.5 Thermo Fisher Scientific
  • 10.2.6 Cook Medical
  • 10.2.7 Baxter International
  • 10.2.8 Johnson & Johnson
  • 10.2.9 Stryker
  • 10.2.10 Fujifilm Holdings
  • 10.2.11 Karl Storz
  • 10.2.12 C.R. Bard
  • 10.2.13 Medtronic
  • 10.2.14 Olympus Corporation
  • 10.2.15 Boston Scientific